[go: up one dir, main page]

PE20010713A1 - Composicion farmaceutica acuosa que contiene ciclesonida - Google Patents

Composicion farmaceutica acuosa que contiene ciclesonida

Info

Publication number
PE20010713A1
PE20010713A1 PE2000001119A PE0011192000A PE20010713A1 PE 20010713 A1 PE20010713 A1 PE 20010713A1 PE 2000001119 A PE2000001119 A PE 2000001119A PE 0011192000 A PE0011192000 A PE 0011192000A PE 20010713 A1 PE20010713 A1 PE 20010713A1
Authority
PE
Peru
Prior art keywords
cyclesonide
substance
pharmaceutical composition
composition containing
aqueous pharmaceutical
Prior art date
Application number
PE2000001119A
Other languages
English (en)
Inventor
Nagano Atsuhiro
Nishibe Yoshihisa
Takanashi Kazuya
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010713(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PE20010713A1 publication Critical patent/PE20010713A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA ACUOSA QUE CONTIENE CICLESONIDA E HIDROXIPROPILMETILCELULOSA DE 0,01% p/p A 30% p/p; LA CICLESONIDA ESTA DISPERSA EN UN MEDIO ACUOSO EN FORMA DE PARTICULAS SOLIDAS, ADICIONALMENTE CONTIENE UNA SUSTANCIA INSOLUBLE EN AGUA Y/O UNA SUSTANCIA DE BAJA SOLUBILIDAD EN AGUA TAL COMO UNA CELULOSA CRISTALINA, UNA SUSTANCIA POLIMERICA SOLUBLE EN AGUA TAL COMO POLIETILENGLICOL, PROPILENGLICOL, ALGINATO, PECTINA, METOXIL PECTINA BAJA, GOMA GUAR, GOMA ARABIGA, CARRAGENINA, METILCELULOSA, CARBOXIMETILCELULOSA, GOMA XANTANO E HIDROXIPROPILCELULOSA. LA COMPOSICION PUEDE SER UTIL PARA EVITAR VARIACIONES EN LAS CONCENTRACIONES DE CICLESONIDA DURANTE LA PRODUCCION
PE2000001119A 1999-10-20 2000-10-19 Composicion farmaceutica acuosa que contiene ciclesonida PE20010713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20

Publications (1)

Publication Number Publication Date
PE20010713A1 true PE20010713A1 (es) 2001-07-13

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001119A PE20010713A1 (es) 1999-10-20 2000-10-19 Composicion farmaceutica acuosa que contiene ciclesonida

Country Status (35)

Country Link
US (2) US8383611B1 (es)
EP (1) EP1227817B1 (es)
JP (1) JP4856338B2 (es)
KR (1) KR100705372B1 (es)
CN (1) CN1198623C (es)
AR (1) AR026073A1 (es)
AT (1) ATE270107T1 (es)
AU (1) AU776587B2 (es)
BG (1) BG65799B1 (es)
BR (1) BRPI0014880B8 (es)
CA (1) CA2388325C (es)
CO (1) CO5251406A1 (es)
CZ (1) CZ297780B6 (es)
DE (1) DE60011924T2 (es)
DK (1) DK1227817T3 (es)
EA (1) EA005201B1 (es)
ES (1) ES2223595T3 (es)
HR (1) HRP20020345B1 (es)
HU (1) HU228894B1 (es)
IL (2) IL148725A0 (es)
ME (1) ME00568B (es)
MX (1) MXPA02003975A (es)
MY (1) MY121175A (es)
NO (1) NO327379B1 (es)
NZ (1) NZ518299A (es)
PE (1) PE20010713A1 (es)
PL (1) PL197537B1 (es)
PT (1) PT1227817E (es)
RS (1) RS50345B (es)
SI (1) SI1227817T1 (es)
SK (1) SK286194B6 (es)
TR (1) TR200200831T2 (es)
TW (1) TWI269655B (es)
WO (1) WO2001028563A1 (es)
ZA (1) ZA200203078B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EP1519734A4 (en) 2002-07-02 2011-02-23 Nycomed Gmbh CICLESONIC STERILE AQUEOUS SUSPENSION
JP4746318B2 (ja) 2002-08-30 2011-08-10 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドと抗ヒスタミン剤との組合せ物を含有するアレルギー性鼻炎の治療用医薬組成物
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
DK1670482T4 (da) 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2588433A1 (en) * 2004-11-17 2006-05-26 Michael R. Robinson Steroid formulation and methods of treatment using same
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
WO2009114521A1 (en) 2008-03-11 2009-09-17 Alcon Research, Ltd. Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
CA2844944A1 (en) 2011-08-18 2013-02-21 Takeda Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DK0431719T3 (da) 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DE69233116T2 (de) 1991-04-03 2004-08-26 Keimowitz, Rudolph M.D., Wayzata Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
ES2205177T5 (es) 1996-02-27 2007-08-01 Teijin Limited Composicion en polvo para administracion nasal.
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
KR100683510B1 (ko) 1998-01-22 2007-02-16 산텐 세이야꾸 가부시키가이샤 플루오로메톨론 현탁형 점안제
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Also Published As

Publication number Publication date
TWI269655B (en) 2007-01-01
YU28102A (sh) 2004-12-31
RS50345B (sr) 2009-11-10
EP1227817B1 (en) 2004-06-30
SI1227817T1 (en) 2004-12-31
EA200200383A1 (ru) 2002-10-31
HRP20020345A2 (en) 2005-10-31
HUP0203756A2 (en) 2003-05-28
IL148725A (en) 2006-12-31
KR100705372B1 (ko) 2007-04-11
NZ518299A (en) 2004-03-26
CN1198623C (zh) 2005-04-27
SK286194B6 (sk) 2008-05-06
CZ297780B6 (cs) 2007-03-28
US20130095146A1 (en) 2013-04-18
NO20021866D0 (no) 2002-04-19
ES2223595T3 (es) 2005-03-01
SK6932002A3 (en) 2002-09-10
PL356190A1 (en) 2004-06-14
IL148725A0 (en) 2002-09-12
BRPI0014880B1 (pt) 2015-08-11
ATE270107T1 (de) 2004-07-15
DE60011924T2 (de) 2005-07-07
AU7953200A (en) 2001-04-30
CZ20021284A3 (cs) 2002-07-17
PL197537B1 (pl) 2008-04-30
EA005201B1 (ru) 2004-12-30
CA2388325C (en) 2007-09-18
ZA200203078B (en) 2003-01-29
KR20020060205A (ko) 2002-07-16
PT1227817E (pt) 2004-11-30
JP2003512330A (ja) 2003-04-02
CN1379673A (zh) 2002-11-13
ME00568A (en) 2011-12-20
HU228894B1 (hu) 2013-06-28
CO5251406A1 (es) 2003-02-28
BR0014880A (pt) 2002-06-11
BG106517A (en) 2002-12-29
DK1227817T3 (da) 2004-11-15
WO2001028563A1 (en) 2001-04-26
BG65799B1 (bg) 2009-12-31
HRP20020345B1 (en) 2006-12-31
MY121175A (en) 2005-12-30
NO20021866L (no) 2002-04-19
ME00568B (me) 2011-12-20
CA2388325A1 (en) 2001-04-26
AU776587B2 (en) 2004-09-16
MXPA02003975A (es) 2003-09-25
DE60011924D1 (de) 2004-08-05
HUP0203756A3 (en) 2004-06-28
JP4856338B2 (ja) 2012-01-18
AR026073A1 (es) 2002-12-26
EP1227817A1 (en) 2002-08-07
TR200200831T2 (tr) 2002-07-22
NO327379B1 (no) 2009-06-22
BRPI0014880B8 (pt) 2021-05-25
HK1051003A1 (en) 2003-07-18
US8383611B1 (en) 2013-02-26

Similar Documents

Publication Publication Date Title
PE20010713A1 (es) Composicion farmaceutica acuosa que contiene ciclesonida
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
CN101557797A (zh) 包括微纤维状纤维素的表面活性剂增稠体系及其制备方法
BR0314269A (pt) Cápsulas contendo composições aquosas de recheio estabilizadas com ciclodextrina derivatizada
PE20130245A1 (es) Composicion de hidrogel de dexibuprofeno transdermico
AR030245A1 (es) Composiciones de gel que contienen metronidazol
DE60130135D1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
BR9812562A (pt) Composição aquosa espessada, processo para limpeza de crostas de cal, e, uso de uma mistura ácida
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
MY135609A (en) Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
CY1108548T1 (el) Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
CO6300911A2 (es) Composiciones agricolas de baja tasa de uso y metodos para su uso
CO5231147A1 (es) Composicion congelante
BRPI0410116A (pt) tablete de cuidado oral
NO20022201L (no) Lösninger inneholdende Epinastin
NO20032788L (no) Modafinil-forbindelse og cyklodekstrinblandinger
BR0318354A (pt) composição para tratamento de pele contendo agente clareador
AR069158A1 (es) Composicion. fluido de recubrimiento de tableta. tableta farmaceutica. proceso
UA74347C2 (uk) Безводна або майже безводна, стабільна рідка композиція
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
CO5580136A1 (es) Distribucion y prepraciones mejoradas de composiciones germicidas
CO5150215A1 (es) Composiciones que tienen estabilidad mejorada
AR023136A1 (es) Composiciones acuosas mejoradas
ATE474550T1 (de) Verwendung von beta-cyclodextrin mit tensiden als perlmuttschimmer-mittel
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term